Logo

American Heart Association

  18
  0


Final ID:

Post-Launch: Clinical Buy-in and Monitoring Results

  • Spatz, Erica  ( YALE UNIVERSITY SCHOOL MEDICINE , New Haven , Connecticut , United States )
  • Bradley, Steven  ( MINNEAPOLIS HEART INSTITUTE , Minneapolis , Minnesota , United States )
  • Ebinger, Joseph  ( Cedars-Sinai Heart Institute , Los Aeles , California , United States )
  • Gluckman, Ty  ( Providence Heart Institute , Portland , Oregon , United States )
  • Author Disclosures:
    Erica Spatz: DO NOT have relevant financial relationships | Steven Bradley: DO NOT have relevant financial relationships | Joseph Ebinger: DO have relevant financial relationships ; Consultant:Edwards Lifesciences:Active (exists now) ; Consultant:Rubicon Founders:Active (exists now) ; Consultant:Viz.ai:Active (exists now) | Ty Gluckman: DO have relevant financial relationships ; Consultant:Premier, Inc.:Active (exists now) ; Individual Stocks/Stock Options:Doximity:Active (exists now) ; Consultant:OptumRx:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:
More abstracts on this topic:
Regulatory requirements for use of novel clinical software

Califf Robert, Mcswain David, Dierks Meghan, Ebinger Joseph

Technical Integration of a Novel Health Tech Innovation into a Large Health System

Beatty Alexis, Basit Mujeeb, Miller Amy

More abstracts from these authors:
How Should We Measure BP in Clinical Trials?

Ebinger Joseph

Panelist

Bradley Steven, Gluckman Ty

You have to be authorized to contact abstract author. Please, Login
Not Available